Mucinex d and Nasonex drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mucinex d (guaifenesin; pseudoephedrine hydrochloride) and Nasonex (mometasone furoate monohydrate). Common drug interactions include incontinence among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people have when they take Mucinex d and Nasonex. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.
What is Mucinex d?
Mucinex d has active ingredients of guaifenesin; pseudoephedrine hydrochloride. It is often used in sinus congestion. eHealthMe is studying from 1,926 Mucinex d users. Check the latest studies of Mucinex d.
What is Nasonex?
Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.
55 people who take Mucinex d and Nasonex together, and have interactions are studied.

What are the common drug interactions of Mucinex D and Nasonex, by gender? *:
female:
- Incontinence (lack of moderation or self-control)
- Inflammation
- Influenza
- Injury
- Irritability
- Memory impairment
- Migraine (headache)
- Mobility decreased (ability to move is reduced)
- Nocturnal fear (fear in night in dreams make to wake up)
- Oedema (fluid collection in tissue)
male:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Renal failure (kidney dysfunction)
- Upper respiratory tract infection
- Wrist fracture
- Abdominal discomfort
- Anaemia (lack of blood)
- Arthralgia (joint pain)
- Asthenia (weakness)
- Bladder cancer
What are the common drug interactions of Mucinex D and Nasonex, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Abdominal distension
- Anxiety
- Arthralgia (joint pain)
- Arthropathy
- Balance disorder
- Blood pressure increased
- Dizziness
- Drug ineffective
- Dyspnoea (difficult or laboured respiration)
- Emotional disorder
30-39:
- Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
- Pituitary tumour benign
- Polyuria (production of too much dilute urine)
- Proteinuria (presence of protein in the urine)
- Rash
- Abdominal discomfort
- Abnormal behaviour
- Alanine aminotransferase increased
- Anaemia (lack of blood)
- Angina pectoris (chest pain due to ischemia of the heart muscle)
40-49:
- Abdominal distension
- Cardiac failure
- Dermatitis herpetiformis (chronic blistering skin condition, characterized by blisters filled with a watery fluid)
- Dizziness
- Oropharyngeal pain
- Rash papular (redness with papule)
- Rash pruritic (redness with itching)
- Sinus headache (headache caused by sinus infections)
- Skin ulcer
- Upper respiratory tract infection
50-59:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Depression
- Emotional distress
- Injection site bruising
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
- Pain
- Renal failure (kidney dysfunction)
- Wrist fracture
60+:
- Decreased appetite
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Blood cholesterol increased
- Colitis (inflammation of colon)
- Constipation
- Diarrhoea
- Diplopia (double vision)
- Dyspnoea (difficult or laboured respiration)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 20 people, 36.36%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 14 people, 25.45%
- Sinusitis (inflammation of sinus): 5 people, 9.09%
- Immunodeficiency Common Variable: 5 people, 9.09%
- Cough: 5 people, 9.09%
- Multiple Myeloma (cancer of the plasma cells): 4 people, 7.27%
- Dyspnea (difficult or laboured breathing): 4 people, 7.27%
- Thyroid Diseases: 3 people, 5.45%
- Thyroid Cancer: 3 people, 5.45%
- Pancreatic Carcinoma (pancreatic cancer): 3 people, 5.45%
* Approximation only. Some reports may have incomplete information.
Do you take Mucinex d and Nasonex?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Mucinex d and Nasonex:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mucinex d:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nasonex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mucinex d and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nasonex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on guaifenesin; pseudoephedrine hydrochloride and mometasone furoate monohydrate (the active ingredients of Mucinex d and Nasonex, respectively), and Mucinex d and Nasonex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Epipen cause Hair Disorder? - 5 seconds ago
- Drug interactions of Hydroxyzine and Lac-Hydrin - 7 seconds ago
- Drug interactions of Hydroxyzine Pamoate and Viibryd - 12 seconds ago
- Drug interactions of Hydroxyzine and Cefotaxime Sodium - 15 seconds ago
- Drug interactions of Citalopram Hydrobromide and Cilostazol - 18 seconds ago
- Could Ranitidine Hydrochloride cause Left Ventricular Dysfunction? - 27 seconds ago
- Could Ranitidine Hydrochloride cause Lumbar Spinal Stenosis? - 28 seconds ago
- Drug interactions of Citalopram Hydrobromide and Echinacea - 36 seconds ago
- Drug interactions of Coumadin and Tobi - 46 seconds ago
- Drug interactions of Citalopram Hydrobromide and Nicoderm Cq - 47 seconds ago